Fundraising Fox株式会社TearExo
Kobe, JP · 1 known investors
Find your way into 株式会社TearExo
Sign up to see every warm intro you have to 株式会社TearExo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社TearExo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.
Investors · 1
Frequently asked questions
- What does 株式会社TearExo do?
- TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.
- Who are 株式会社TearExo's investors?
- 株式会社TearExo's investors include Kobe University Capital.
- Where is 株式会社TearExo headquartered?
- 株式会社TearExo is headquartered in Kobe, JP.